MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 296 filers reported holding MEDICINES CO in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $70,000,000 | +91.9% | 1,400,000 | +40.0% | 2.81% | +90.3% |
Q2 2019 | $36,470,000 | +86.4% | 1,000,000 | +42.9% | 1.48% | +84.6% |
Q1 2019 | $19,565,000 | +2.2% | 700,000 | -30.0% | 0.80% | +12.7% |
Q4 2018 | $19,140,000 | -36.0% | 1,000,000 | 0.0% | 0.71% | -8.9% |
Q3 2018 | $29,910,000 | -25.9% | 1,000,000 | -9.1% | 0.78% | -9.3% |
Q2 2018 | $40,370,000 | +36.2% | 1,100,000 | +22.2% | 0.86% | +131.3% |
Q1 2018 | $29,646,000 | +20.5% | 900,000 | 0.0% | 0.37% | 0.0% |
Q4 2017 | $24,606,000 | +32.9% | 900,000 | +80.0% | 0.37% | +16.3% |
Q3 2017 | $18,520,000 | -11.4% | 500,000 | -9.1% | 0.32% | -12.6% |
Q2 2017 | $20,906,000 | +327.5% | 550,000 | +450.0% | 0.36% | +234.9% |
Q1 2017 | $4,890,000 | +188.2% | 100,000 | +100.0% | 0.11% | +186.8% |
Q4 2016 | $1,697,000 | – | 50,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |